MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2
- 357 Downloads
Ovarian cancer (OC) is a major cancer-related mortality among women. Recent studies suggest that many microRNAs (miRNAs) were dysregulated and involved in tumorigenesis of OC. The present study investigated the role of miR-25 in the development and progression of OC. The expression of miR-25 was increased in OC tissues and cell lines. Inhibition of miR-25 remarkably suppressed proliferation, migration, and invasion of OC cells. Large tumor suppressor 2 (LATS2), a tumor suppressor, was confirmed to be a direct target of miR-25 in OC cells. Moreover, restoration of LATS2 significantly attenuated the oncogenic effects of miR-25. Together, our data suggest an oncogenic role of miR-25 in OC and a potentially novel diagnostic and therapeutic target for OC treatment.
KeywordsOvarian cancer MiR-25 Proliferation Migration Invasion
Conflicts of interest
- 5.Kentwell J, Gundara JS, Sidhu SB: Noncoding RNAs in endocrine malignancy. The oncologist 2014Google Scholar
- 7.Li W, Liu Z, Chen L, Zhou L, Yao Y: MicroRNA-23b is an independent prognostic marker and suppresses ovarian cancer progression by targeting runt-related transcription factor-2. FEBS letters. 2014;588(9):1608–15.Google Scholar
- 8.Xia J, Guo X, Yan J, Deng K: The role of mir-148a in gastric cancer. Journal of cancer research and clinical oncology. J Cancer Res Clin Oncol. 2014;140(9):1451–56.Google Scholar
- 11.Wang X, Meng X, Li H, Liu W, Shen S, Gao Z: MicroRNA-25 expression level is an independent prognostic factor in epithelial ovarian cancer. Clin Translational Oncol: Off Publ Federat Spanish Oncol Soc Natl Cancer Institute Mexico. Biochem Biophys Res Commun. doi: 10.1007/s12094-014-1178-6.
- 20.Adler JJ, Johnson DE, Heller BL, Bringman LR, Ranahan WP, Conwell MD, et al. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of angiomotin by the LATS1/2 protein kinases. Proc Natl Acad Sci U S A. 2013;110:17368–73.PubMedCentralPubMedCrossRefGoogle Scholar
- 23.Takahashi Y, Miyoshi Y, Takahata C, Irahara N, Taguchi T, Tamaki Y, et al. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin Cancer Res: Off J Am Assoc Cancer Res. 2005;11:1380–5.CrossRefGoogle Scholar
- 26.Xia Y, Gao Y: MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2. Biochem Biophys Res Commun. 2014;447(3):446--51.Google Scholar